Clinical Trial Details
— Status: Completed
Administrative data
| NCT number |
NCT02957747 |
| Other study ID # |
00614 |
| Secondary ID |
|
| Status |
Completed |
| Phase |
N/A
|
| First received |
|
| Last updated |
|
| Start date |
June 12, 2017 |
| Est. completion date |
May 1, 2020 |
Study information
| Verified date |
December 2020 |
| Source |
VISN 17 Center of Excellence |
| Contact |
n/a |
| Is FDA regulated |
No |
| Health authority |
|
| Study type |
Interventional
|
Clinical Trial Summary
Lifetime sexual trauma (ST) (i.e., behaviors that range from unwanted sexual touching to
attempted or completed rape) is a significant social and public health problem among women
Veterans. For women Veterans, lifetime ST can occur prior to, during or after military
service. ST is associated with multiple difficulties and risks, including posttraumatic
stress disorder (PTSD), intimate partner violence (IPV), and alcohol misuse. Providing an
effective, integrated, and low-cost intervention that targets ST-related risks for women
Veterans with lifetime ST would advance clinical care for these vulnerable women.
This research will develop and assess a computer-delivered intervention (Safety and Health
Experiences Program; SHE) that will provide a screening and brief behavior intervention for
women Veterans with any lifetime ST. More specifically, the intervention, SHE, will address
interrelated health concerns for women Veterans with ST (i.e. alcohol misuse, IPV, and PTSD).
SHE will be designed to provide individualized assessment, feedback, and referrals for women
Veterans with any lifetime ST. SHE will take place within a primary care setting. Primary
care visits are frequent points of health care contact for women Veterans making the visit
itself the ideal, and possibly only, opportunity to provide behavioral interventions.
This study will lay the groundwork for a larger clinical trial of the SHE program in multiple
VA primary care settings. If effective, the intervention, SHE, represents an innovative and
low cost service for early identification and intervention that could be implemented
nationwide with ease and speed to address the needs of women Veterans with lifetime ST. The
long-term goal of the project is to make a significant impact on advancing health services
research by introducing and testing a novel and potentially powerful service tool that may
improve service delivery to address the co-occurring health concerns for women Veterans with
any lifetime ST.
Description:
The VA Women's Health Research Agenda underscores the importance of improving the safety and
health outcomes of returning Veteran women. With greater numbers of women joining the
military, the need for gender-specific VA-based interventions is increasingly important.
Posttraumatic stress disorder (PTSD), intimate partner violence (IPV), and alcohol use are
closely interrelated and significant concerns for women Veterans with a history of sexual
trauma (ST). Given that screening for military sexual trauma (MST) is mandated within VAs, a
computer delivered intervention has the potential to be easily integrated into the standard
of care for women who screen positive for MST and/or other lifetime STs, increasing the
identification of high-risk women Veterans. This intervention will provide a computer-based
intervention on a VA issued laptop that could improve delivery service and fill a healthcare
gap for a vulnerable Veteran population.
The long-term goal of the project is to make a significant impact on advancing health
services research by introducing and testing a novel and potentially powerful service tool
that may improve service delivery to address the co-occurring health concerns for VA women
with lifetime ST. The intervention, Safe and Healthy Experiences (SHE), a brief modular,
computer-based intervention, will target interrelated health risks for women Veterans with
lifetime ST (i.e. alcohol misuse, IPV, and PTSD). SHE will provide individualized assessment,
feedback, and referrals for women Veterans with lifetime ST. The intervention is based on
motivational interviewing (MI), a well-defined intervention strategy that has yielded
particularly promising results in a range of clinical issues, including interpersonal
violence, and a range of patient populations, including male and female Veterans. MI is a
collaborative and non-confrontational approach that emphasizes increasing a participant's
awareness of successful steps towards well-being. MI is consistent with an empowerment model,
which is a highly recommended intervention model for victimized women and both MI and an
empowerment model converge on important principles for intervening with victimized women.
Findings from the study will provide the necessary groundwork to examine the efficacy of SHE
in a future, large clinical trial. If the SHE intervention is found to be feasible,
acceptable and efficacious in improving outcomes for women Veterans with lifetime ST, the
ultimate goal would be for the program to be integrated into clinical care and widely
disseminated. There are two phases of research directed toward these aims: 1) develop and
refine an integrated screening and behavior intervention for VA women with lifetime ST in a
brief modular computer-based format that can be administered in a VA primary care setting,
and 2) collect data on the feasibility, acceptability, and initial efficacy of the
intervention in improving the health of VA women, and increasing utilization of treatment and
resources.
The study aims are to:
1. Develop the preliminary computer-based intervention, incorporating information gained in
informant interviews.
2. Perform a small open trial (n = 20) of SHE to assess feasibility of recruitment of
target population and acceptability of intervention and study procedures.
3. Conduct an initial randomized control trial in a sample of 150 women Veterans who screen
positive for lifetime sexual trauma (ST) and have at least one risk factor (i.e., screen
positive for intimate partner violence (IPV), posttraumatic stress disorder (PTSD),
and/or heavy drinking) to demonstrate the feasibility of SHE and the acceptability of
SHE via participant report of ease of use, helpfulness, and overall satisfaction.
4. Examine preliminary evidence for the hypotheses that, relative to the control condition,
screening and referral only (SR), SHE will result in:
- Decreases in the number of risks (i.e., heavy drinking (4+ drinks on one occasion),
screen positive for PTSD, screen positive for IPV) at the 2- and 4-month follow-up
(primary).
- Increases in resource and treatment utilization over the 2- and 4-month follow-up
period (secondary).
The data will be used to demonstrate whether the effects of the intervention look promising
to support a future large-scale randomized control trial and to suggest, in concert with
results from clinical trials in related fields, the range of effect sizes that would be
reasonable to expect in a future trial.
This is a multi-site study. At the Providence, RI based site (Women and Infants Hospital and
Brown University), the specialized computer-based assessment and interactive intervention
sessions will be developed and designed and staff members will also assist with data
management. The Central Texas VA Healthcare System site will be the data collection site and
the main site for participant recruiting, consenting, enrollment, intervention and follow-up.
Staff at the two sites will work collaboratively throughout the project to supervise study
staff, for reporting to the DOD and IRB's and in designing the assessment and intervention
sessions, however, only the study staff at the Central Texas site will have access to
participant PHI.